Order Article Reprints
Journal: Pharmaceuticals, 2025
Volume: 18
Number: 1898
Article:
First-in-Human Phase I Clinical Trial of SLC-391, a Novel and Selective AXL Inhibitor, in Patients with Advanced Solid Tumours
Authors:
by
Zaihui Zhang, Donna Morrison, Liang Lu, Madhu Singh, Jun Yan, Natasha Leighl, Scott A. Laurie and Sebastien Hotte
Link:
https://www.mdpi.com/1424-8247/18/12/1898
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.